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A B S T R A C T
The aim of this study was to develop a novel iron oxide nanoparticle synthesis method with in-situ surface
coating. For this purpose multiple emulsions were used as microreactors for the first time and magnetic iron
oxide particles synthesized in the core of cationic solid lipid nanoparticles. DLS, SEM, TEM, VSM, Raman
Spectrometer, XRD, and XPS techniques were performed for characterization of the magnetic nanoparticles.
Obtained magnetic nanoparticles are superparamagnetic and no additional process was needed for surface
adjustments. They are positively charged as a result of cationic lipid coating and has appropriate particle size ( <
30 nm) for drug or nucleic acid delivery. Structure analysis showed that magnetic core material is in the form of
magnetite. Saturation magnetization value was measured as 15–17 emu g−1 for lipid coated magnetic
nanoparticles obtained by multiple emulsion method which is reasonably sufficient for magnetic targeting.
1. Introduction
In order to carry genetic materials or drugs for clinical uses,
efficacious, targetable and highly reliable transport systems are needed
[1–3]. Delivery of drugs or genes to the target under a magnetic field is
one of the promising delivery method both in vitro and in vivo [4,5].
Iron oxide nanoparticles can be used for this purpose. The main
problems in producing magnetic iron oxide (FenOm) nanoparticles are
the low magnetization values and the wide range of particle size
distribution. Such delivery systems also need a biocompatible, non-
toxic surface coating for loading drugs, to form complexes with nucleic
acids and increasing bioavailability in the organism [3,6–8].
As to the previous data, synthesis of iron oxide nanoparticles by co-
precipitation method is the simplest and most widely used method. In
this method magnetic nanoparticles (MNPs) synthesized by precipitat-
ing aqueous solutions of Fe+2 and Fe+3 ions using a base as hydro-
xylation agent. However, this method has some disadvantages about
particle shape control, particle size distribution and particle aggrega-
tion [9–13].
Obtaining of MNPs using the microemulsion technique is another
method [13–18]. Considerably small nanoparticles which are appro-
priate for in vivo applications can be obtained by this method. Further,
the particle size distribution is also quite homogeneous. Simple
mixtures of water/oil microemulsions to obtain MNPs can be given
as examples of this method. While one of such microemulsions
contains a metallic salt or mixtures of iron oxide compounds, the
other one carries the reducing agent. Due to their small particle size,
the microemulsion droplets exhibit Brownian motion and hence they
form a colloidal state. During these movements momentary dimers or
aggregates are formed, ensuring exchanges between the microemulsion
inner phases and chemical reaction takes place to form MNPs [19–21].
One of the significant problem encountered in the synthesis of
MNPs with iron compounds is the tendency of the reaction to
synthesize non-magnetic iron compounds. This is mainly caused as a
result of the effect of dissolved oxygen in the solutions. The dissolved
oxygen must therefore be removed from the medium. The removal is
performed by creating a nitrogen gas environment [18,22].
Maintaining pH of the medium in the acidic range is another solution
[23]. For the multiple emulsion method that we prepared, solutions of
Fe+2 and Fe+3 are in the form of droplets surrounded by a lipid layer of
water/oil microemulsion. In this situation, the rate of contact with the
external environment or with atmospheric oxygen is lower. Another
point is that the lipids participating in the microemulsion composition
exert a protective effect by reducing the pH level, since they contain
fatty acids. Briefly, in this work we developed a novel magnetic
nanoparticle synthesis method with an appropriate particle size, zeta
potential, and sufficient magnetic property for nucleic acid and drug
targeting by combining advantages of microemulsion and multiple
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emulsion methods.
2. Experimental
2.1. MNP Synthesis
To obtain triangular phase diagram of water in oil (w/o) micro-
emulsion is the first step of synthesis method. Microemulsions were
formed with glyceryl monostearate as oil phase, Span 80 as non-ionic
surfactant, ethanol as co-surfactant and Fe+2 and Fe+3 ionic solutions
as water phase (w1/o) over the lipid melting point.
Dimethyldioctadecylammonium bromide (DDAB) was used for adding
cationic property to the MNPs. Surfactant and co-surfactant were
mixed and brought to a temperature 10 °C higher than the melting
temperature of the solid lipids. Then, the mixture was titrated with the
water phase, at this temperature, until turbidity occurs and transparent
regions belongs to w/o microemulsion area in triangular phase
diagram was defined. A formulation which has the largest volume of
inner water phase was selected from this transparent area. Selected
microemulsion was used as an interior emulsion of multiple emulsions
(w1/o/w2), Tween 80 was used as an outer hydrophilic surfactant and
ultra-pure water used as an outer water phase (w1/o/w2). Afterwards
2N NH4OH was used to increase pH of the system. [OH
-] ions were
leaked to the interior water phase of the multiple emulsion and
reaction occurred between (1 M Fe+2) and (2 M Fe+3) solutions [24].
Magnetic iron oxide particles were synthesized in the core of cationic
lipids.
1 mL of hot multiple emulsions with magnetic core was taken in a
pre-heated injector and dropped into the ice-cold distilled water. MNPs
were formed when hot multiple emulsion droplets met with cold water
[25–27]. MNPs were collected by using a neodium magnet and washed
twice with distilled water and the characterization studies were carried
on (Fig. 1) [12].
To understand the effects of formulation on magnetization and
magnetic core material, one formulation (NP-Ø) was prepared with the
same way as described above, and instead of (1 M Fe+2) and (2 M Fe+3)
solutions only ultra-pure water was used in the interior water phase of
multiple emulsions (w3/o/w2).
2.2. Measurements
Dynamic light scattering (DLS) measurements were performed to
determine particle size of MNPs at 25 °C using a Zetasizer Nano ZS
(Malvern, UK).
Magnetic properties of nanoparticles were characterized using
Vibrating Sample Magnetometer (VSM) (Lakeshore, USA). MNPs were
also synthesized by a well-known co-precipitation method (MNP-CoP)
with the same external conditions to compare the magnetization degree
of MNPs obtained by multiple emulsions method (MNP-MuE).
The morphology of MNPs was visualized by using Transmission
Electron Microscope (TEM) and Scanning Electron Microscope (SEM).
For these measurements a drop of diluted MNPs was placed on a TEM
grid, allowed to dry in air and visualized.
Confocal Raman scattering measurements were performed on
lyophilized MNP powders with Raman spectrometer (Princeton
Instruments) equipped with a He–Ne laser source giving an excitation
wavelength of 633 nm and/or Ar+ laser source giving an excitation
wavelength of 488 nm. The laser was focused using a 100x objective
and Raman scattering was recorded using a 150 and 600 groves/mm
gratings. Characteristic peaks related to magnetic components in the
samples were normalized and identified.
For the X-ray diffraction (XRD) and X-ray photoelectron spectro-
scopy (XPS) analysis, MNP suspensions were dropped onto cover slips
and were allowed to dry under N2 atmosphere. XRD measurements
were collected with Phillips X'Pert Pro X-ray diffractometer operated at
50 kV and 50 mA with monochromatic Cu-Kα radiation
(λ=0.15406 nm) at scan range of 10° < 2θ < 80°. XPS spectrum was
recorded on Thermo Scientific K-Alpha System with monochromatic
Al-Kα radiation (λ=1486.6 eV) with pass energy of 50 eV as the X-ray
source. XPS spectra were measured in 1.0 eV intervals within 1361
energy steps. A broad scan of all components, and expanded scans of
iron and nitrogen ions were collected. XPS mass percentages of the
surface elements were calculated.
3. Results and discussion
The most widely used method for magnetic nanoparticle production
Fig. 1. Schematic illustration of synthesis and purification of MNPs by multiple emulsions method.
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is co-precipitation method. Although the size of the MNPs obtained
with this method can be small enough, there is no mechanism to
control particle size and surface characteristics. The particle size
distribution graph occupies a wide area [polydispersity index (PDI) is
larger than 0.3] with MNP-CoP. There was insufficient homogeneity in
size of MNPs. In the method that we developed, the iron compounds
are in the form of droplets in limited volume reaction pools, within the
inner water phase of multiple emulsions. Since the droplet size is
limited by the reaction volume for production of MNPs, the particle
sizes also become more controllable. For this purpose, firstly w/o
microemulsions were prepared. The w/o microemulsion area was
determined by the aid of triangle phase diagram and transparent water
in oil systems were formed (Fig. 2). A formulation which has the largest
volume of inner water phase was selected in transparent systems area
of triangle phase diagram. Then, MNPs were obtained and character-
ized as described (Table 1).
When MNPs used without coating, they are cleared from body in a
short time by the immune system. While their biocompatibility is a
positive trait, they need to be coated with polymers or lipids in their
applications as a delivery systems for drug or genes [3,16,28–31]. In
addition to the coating process, it requires a second purification step to
remove solvents [6]. In the system that we developed, MNPs synthe-
sized in multiple emulsions appear in the form of solid lipid nanopar-
ticles. Since the synthesis of MNPs spontaneously ensures the produc-
tion in lipid-coated form there is no need an extra coating process as
well as following purification steps. Therefore, a delivery system that is
adequate to the specific purpose may also be produced by using
another lipids used for the coating. In the system that we developed,
a cationic lipid coating of the MNPs was ensured by the use of DDAB as
in the oil phase of the microemulsion, realizing the cationic zeta
potential value as a proof of cationic lipid coating after washing and
magnetic separation processes [20,32,33]. Table 1 shows the particle
size, PDI, and zeta potential of MNP-MuE and MNP-CoP. Zeta
potential measurements showed that negative values were determined
when measuring of MNP-CoP, while positive values were found in
MNPs which were obtained by multiple emulsion method because of
cationic lipid coating in a single step.
The magnetic properties of MNP-MuE were analyzed by VSM. The
magnetic properties such as saturation magnetization (Ms), remanent
magnetization (Mr) and coercivity (Hc) were evaluated from the
magnetization hysteresis of MNPs. As seen in Fig. 3, MNPs had a
paramagnetic behavior and Mr and Hc values are approximately zero.
Although saturation magnetization of MNP-CoP was higher than the
coated samples that we prepared, coated MNPs had significant Ms
values for magnetic targeting of drugs or nucleic acids
[11,28,29,34,35]. Ms value was measured as 15–17 emu g−1 for lipid
coated MNP-MuE while 2–3 times higher Ms values were reported on
previous data for MNP-CoP [6,18].
Representative SEM and TEM micrographs of MNP-MuE are
shown in Fig. 4. These micrographs indicates that MNPs were covered
with lipids and some agglomeration was also observed among MNPs.
This may be caused by drying process on the copper grids for
preparation to imaging instrument. SEM micrographs showed that
black iron oxide core nanoparticles were covered with light grey colored
lipid membrane (Fig. 4a) on the other hand the particles were more
detectable in globular shape and narrow size distribution with TEM
(Fig. 4b). Center of the spherical nanoparticles were darker than the
walls of the spheres. TEM and SEM micrographs reflects particle size
more directly than DLS method [36,37]. When micrographs were
analyzed, particle size was measured as smaller than 30 nm, which
agrees well with the superparamagnetic character of the particles
[18,31,35].
VSM measurements indicated that MNPs synthesized by multiple
emulsions are superparamagnetic. Raman spectroscopy studies were
performed to identify the magnetic core material of MNP-MuE. Raman
spectra measurements were usually performed in the literature with a
He–Ne laser source giving an excitation wavelength of 633 nm for
MNPs [38,39]. We also used Ar+ laser source giving an excitation
wavelength of 488 nm to reduce the high background fluorescence
caused by lipid membrane and the Raman spectra were normalized
with a software. Lipids yield large amount of fluorescence background.
This fluorescence radiation might be coming from electron returning to
ground state by emitting a light over time in addition to crystal
vibrations (phonons). Fluorescence background, since it can effectively
suppress the phonon spectrum, need to be subtracted from the data to
obtain clean phonon spectrum. As a reference and to use for compar-
ison nanoparticles without magnetic core (NP-Ø) were also evaluated
Fig. 2. Triangular phase diagram of w1/o microemulsion formed with glyceryl
monostearate as oil phase, Span 80 as non-ionic surfactant, ethanol as co-surfactant
and Fe+2 and Fe+3 ionic solutions as water phase.
Table 1
Characterization results of MNP-MuE and MNP-CoP. SD stands for standard deviation.
Formulation Particle Size (nm) (± SD) PDI ( ±SD) Zeta Potantial - ζ (mV) ( ± SD)
MNP-MuE 139,9 ( ± 2,902) 0,160 ( ± 0,023) 41,1 ( ± 1,641)
MNP-CoP 9,52 ( ± 0,204) 0,338 ( ± 0,045) −25,9 ( ± 0,656)
Fig. 3. Magnetic hysteresis of MNP-MuE.
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with Raman spectroscopy. These particles were only consist of the lipid
component of the MNPs (Fig. 5).
In Fig. 5, Raman spectra of MNP-CoP were measured with
excitation wavelength of 633 nm and 488 nm dispersed using a grating
of 150 groves/mm. Magnetite has a poor Raman spectrum and high
laser power induced phase transformation from magnetite to maghe-
mite and haematite. Magnetite has a Raman shift peak at 668 cm−1,
maghemite has strong peaks at 350 cm−1, 500 cm−1 and 700 cm−1
while haematite has strong peaks at 225 cm−1, 299 cm−1 and
412 cm−1[39]. From Fig. 5, Raman shift peaks of haematite (α-
Fe2O3) and maghemite (γ-Fe2O3) can be observed. Therefore, it can
be said that in our study, MNP-CoP are in α-Fe2O3 structure which is
more stable polymorph than γ-Fe2O3 or Fe3O4 forms. NP-Ø has its own
characteristic Raman spectrum which does not resembles that of iron
oxide structures. No significant peaks were observed in the Raman
spectrum in wavenumbers lower than 1000 cm−1.
Raman spectra measurements were also done for MNPs obtained
by multiple emulsion method as well. MNP-MuE samples had also high
background fluorescence caused by lipid membrane and they were
normalized by excluding the fluorescence (Fig. 6). MNP-MuE and NP-
Ø has strong peaks at 1450 cm−1 and 3000 cm−1 however MNP-MuE
has also peaks between 500 cm−1 and 1000 cm−1 which is absent for
NP-Ø particles (Fig. 5).
Peaks between 500 cm−1 and 1000 cm−1 are belong to magnetic
particles in the core of lipid membrane. There were no significant peaks
under 500 cm−1 like maghemite of haematite. Lipid membrane coating
may protect iron oxide compounds from oxidation or phase transfor-
mation caused by high laser power. MNP-MuE has more compatible
peaks belongs to magnetite.
Lipid structures and iron oxide compounds have their own char-
acteristic Raman Spectra and were not in resemblance to each other's
spectrum. On the other hand, MNP-MuE and NP-Ø has common peaks
because of their lipid membrane; MNP-MuE and MNP-CoP has
common peaks because of having peaks under 1000 cm−1. Magnetic
particles are in the structure of α-Fe2O3 for the co-precipitation
method. External conditions such as O2 atmosphere and pH of the
system may cause oxidation and Fe2O3 particles may have been
synthesized instead of Fe3O4 particles [18,22]. In case of our method,
Raman peaks showed that MNP-MuE has protective lipid cover on the
superparamagnetic core material and structure of the magnetic core
has peaks around 650 cm−1 to 700 cm−1 as in the magnetite structure.
Crystalline structure of MNPs were determined by XRD method
and obtained data were illustrated in Fig. 7. Impurity was detected due
to amorphous lipid structures but well-defined peaks were also
detected. Fig. 7a shows the XRD pattern of MNP-MuE and graphic
was normalized by subtracting the lipid signals. To use for comparison
NP-Ø were also evaluated and compared with the MNP-MuE without
normalizing the data in the Fig. 7b.
The XRD data in Fig. 7a shows the characteristic peaks of Fe3O4
and α-Fe2O3 together. The line profile of peaks are both fitted to the
structure of Fe3O4 for peaks 311, 222, 422; α-Fe2O3 for peaks 104,110,
202. FeO was determined for the peak 101 [40]. The results of the XRD
Fig. 4. SEM (a) and TEM (b) micrographs of MNP-MuE.
Fig. 5. Raman spectra of MNP-CoP and NP-Ø (no magnetic core) with excitation
wavelength of 633 nm and 488 nm with the grating of 150 groves/mm. Blue line
represents NP-Ø (488 nm), green and red lines represent Raman spectra of MNP-CoP
sample obtained with excitation wavelengths of 488 nm and 633 nm, respectively. (For
interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article.)
Fig. 6. Raman spectra of MNP-MuE collected with excitation wavelength of 633 nm
(blue line) and 488 nm (black line) with 150 groves/mm grating. (For interpretation of
the references to color in this figure legend, the reader is referred to the web version of
this article.)
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are agreed with the measurements of Raman Spectroscopy and super-
paramagnetic core material was found mainly in the form of Fe3O4 or
its oxidized derivate α-Fe2O3. Phase transformation from Fe3O4 to the
α-Fe2O3 may cause due to high laser application and drying process
while sample preparation.
The XRD patterns of MNP-MuE and NP-Ø were combined in the
Fig. 7b. Patterns are almost similar. The only difference is the absence
of the magnetic materials in the formulation of NP-Ø. There is no
significant peaks were observed which resembles that of iron oxide
structures. However MNP-MuE has common peaks that are identified
in the normalized XRD pattern in Fig. 7a.
XPS technique was used to examine surface of the synthesized
MNPs. Results were illustrated in the Fig. 8 and XPS mass percentages
of the surface elements of MNPs are shown in the Table 2.
Surface ions can be detectable and distinguishable in XPS. From the
bands of XPS spectra, the absorption sites and the interactions between
magnetic materials and the lipids can be identified as well. A broad
scan of all components of MNP-MuE, and expanded scans of iron and
nitrogen ions were shown in the Fig. 8. Expanded photoelectron
spectra of Fe 2p at 710.3 and 723.5 eV are the characteristic peaks of
iron oxides. Peaks are identified as Fe 2p3/2 and 2p1/2, respectively
[41]. This shows the molecule is Fe3O4 and it is under oxidation state.
This data is compatible to the Raman Spectra results and the XRD
analysis. Both analysis identified magnetic core material in the form of
Fe3O4 or its more stable and oxidized derivate α-Fe2O3.
The spectra of N1s bands in Fig. 8 were also expanded. Band at
397.1 eV is assigned to amino groups of the lipids in the formulation.
The binding energy at 402.2 eV was attributed to the cationic amino
groups (-N+) that were reflects the presence of cationic lipid DDAB
[42]. XPS spectra of the NP-Ø was also examined. XPS mass
percentages of the C, N, O, and Fe were calculated in Table 2. The
Fig. 7. X-ray diffraction patterns of MNP-MuE and NP-Ø, a. Normalized XRD pattern of MNP-MuE, b. XRD pattern comparison of unnormalized MNP-MuE and NP-Ø.
Fig. 8. X-ray photoelectron spectra of the synthesized MNP-MuE. A broad scan of all components and expanded scans of iron and nitrogen ions. The left inset is the expanded spectrum
of Fe 2p and the right inset is the expanded spectrum of N 1s.
Table 2
XPS mass percentages of the surface elements of MNPs.
XPS (%) Calculated value (%)
MNP-MuE NP-Ø
C 79,75 91,71 N/A
N 1,24 1,58 N/A
O 16,97 6,71 N/A
Fe 2,03 0 11,504 (MNP-MuE)
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mass percentage of the Fe in the MNP formulation was also calculated
and placed in Table 2. MNP-MuE and NP-Ø has similar nitrogen mass
percentage due to cationic lipid DDAB. Fe was not found in NP-Ø as it
was expected. When we compare the XPS mass percentage of Fe on the
surface of MNP-MuE to the calculated Fe in MNP-MuE, there is a 5.6
times more Fe calculated for MNP-MuE as a result of most of the
magnetic materials were coated by lipid membrane as a structure of
multiple emulsions [18].
4. Conclusion
The aim of this study was to obtain MNPs using multiple emulsions
as microreactors. For this aim, (1 M Fe+2) and (2 M Fe+3) solutions
were incorporated into the inner water phase of microemulsion and 2N
NH4OH was added in the outer phase of the multiple emulsion. [OH
-]
ions leaked to the interior water phase of the multiple emulsion (w1/o/
w2) and reacted with Fe solutions. Therefore, magnetic iron oxide
particles formed in the core of cationic solid lipid nanoparticle with
optimal size and surface properties. These obtained MNP-MuE nano-
particles had similar magnetization hysteresis compared to those
obtained by co-precipitation method and showed superparamagnetic
characteristics. Particle size analysis were done on SEM and TEM
micrographs and was measured smaller than 30 nm which was found
compatible with superparamagnetic character. VSM measurements
showed that MNP-MuE nanoparticles are superparamagnetic.
Magnetic core materials structure was analyzed and it was found in
the form of Fe3O4 or its more stable and oxidative derivate α-Fe2O3
with Raman spectroscopy, XRD and XPS techniques.
Prepared MNP-MuE nanoparticles did not need any additional
process for surface charge adjustments, they were already positively
charged due to cationic lipid coating. The properties of MNPs such as
size, zeta potential, and volume of magnetic core or lipid membrane
could be adjusted according to the requirements of the desired delivery
material. In this system MNPs were obtained by the use of a cationic
lipid as the oil phase of the microemulsion, has potential to form
complexes by its direct electrostatic interaction with DNA or any other
anionic drug molecules and oil soluble compounds.
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